Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01040962 · ClinicalTrials.gov registry record
Fall Risk Assessment in People With Diabetic Neuropathy
A clinical trial of Diabetic Peripheral Neuropathy, sponsored by Stephen D. Jernigan, PT, PhD.
- Completed
- Registry status
- 37
- Enrollment target
- 2
- Study locations
NCT01040962 is a study of Diabetic Peripheral Neuropathy that has completed, run by Stephen D. Jernigan, PT, PhD. The registered enrollment target is 37 participants, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01040962, a study of Diabetic Peripheral Neuropathy, has completed, sponsored by Stephen D. Jernigan, PT, PhD.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 2
- Study locations
Study Summary
Fall risk is increased in people with diabetic peripheral neuropathy (DPN) and yet, minimal research has been conducted to identify appropriate fall risk assessment tools and improve our understanding of falls in these individuals. Purpose: The primary purpose of this study is to establish a foundation of knowledge needed to address falls in people with DPN. This will be accomplished through 1) comparing the validity of 4 fall risk assessment tools, 2) identifying risk factors for falls and 3) determining how quality of life is influenced by factors related to falls in people with DPN.
Conditions Studied
Study Locations (2)
Kansas
- University of Kansas Medical Center - Kansas City
Missouri
- North Kansas City Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01040962
The ClinicalTrials.gov registry entry for NCT01040962 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (71% lower). The listed sponsor is Stephen D. Jernigan, PT, PhD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Peripheral Neuropathy appearing as the primary indexed condition, and to 0 interventions.
NCT01040962 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Missouri.
Frequently Asked Questions
What is clinical trial NCT01040962 about?
NCT01040962 is a clinical study titled "Fall Risk Assessment in People With Diabetic Neuropathy". Fall risk is increased in people with diabetic peripheral neuropathy (DPN) and yet, minimal research has been conducted to identify appropriate fall risk assessment tools and improve our understanding of falls in these individuals. Purpose: The primary purpose of this study is to establish a foundat...
What is the current status of trial NCT01040962?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2008-08. Estimated completion is 2010-12.
What conditions does trial NCT01040962 study?
This clinical trial studies the following conditions: Diabetic Peripheral Neuropathy.
Who is sponsoring clinical trial NCT01040962?
This trial is sponsored by Stephen D. Jernigan, PT, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01040962 being conducted?
This trial has 2 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Walking Function in Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Balance Control and Recovery in Diabetes Peripheral Neuropathy
RECRUITING · NA
-
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.